Fig. 3.
Fig. 3. Associations between FFS and BCL-2 expression in HRS cells for patients treated with ABVD or equivalent regimens. / (A) All patients. (B) patients with Ann Arbor stage III or IV. ○ indicates BCL-2+ cHD; ⋄, BCL-2−cHD.

Associations between FFS and BCL-2 expression in HRS cells for patients treated with ABVD or equivalent regimens.

(A) All patients. (B) patients with Ann Arbor stage III or IV. ○ indicates BCL-2+ cHD; ⋄, BCL-2−cHD.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal